Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine clinical trials--a statistical primer.

D V Mehrotra1

  • 1Merck Research Laboratories, North Wales, PA 19454, USA. devan_mehrotra@merck.com

Journal of Biopharmaceutical Statistics
|August 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current Practices in Choosing Estimands and Sensitivity Analyses in Clinical Trials: Results of the ICH E9 Survey.

Therapeutic innovation & regulatory science·2018
Same author

Rank-based principal stratum sensitivity analyses.

Statistics in medicine·2013
Same author

Statistical considerations for noninferiority/equivalence trials in vaccine development.

Journal of biopharmaceutical statistics·2006
Same author

Relative risk estimation and inference using a generalized logrank statistic.

Statistics in medicine·2001
Same author

Simultaneous testing strategy for comparing two treatments in a stratified binomial trial.

Journal of biopharmaceutical statistics·2000
Same author

Minimum risk weights for comparing treatments in stratified binomial trials.

Statistics in medicine·2000
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study covers critical statistical challenges in vaccine development, comparing vaccine and drug clinical trials. It highlights key considerations for ensuring robust trial design and data analysis.

Area of Science:

  • Biostatistics
  • Vaccinology
  • Clinical Trials

Background:

  • Vaccine development involves complex statistical considerations throughout its lifecycle.
  • Understanding these statistical issues is crucial for successful vaccine research and regulatory approval.

Purpose of the Study:

  • To outline significant statistical challenges encountered in vaccine development.
  • To differentiate statistical approaches in vaccine versus drug clinical trials.

Main Methods:

  • Review and discussion of statistical methodologies.
  • Comparative analysis of drug and vaccine clinical trial designs.

Main Results:

  • Identification of common statistical pitfalls in vaccine trials.

Related Experiment Videos

  • Elucidation of unique statistical needs for vaccine efficacy and safety assessments.

    • Conclusions:

    • Effective statistical planning is paramount for robust vaccine development.
    • Tailored statistical strategies are essential for both drug and vaccine clinical trials.